Agios to Present Updated Clinical Proof-of-Concept Data from the Phase 2 Study of Mitapivat in Thalassemia in Oral Presentation at the European Hematology Association Annual Congress
– Data Supporting Utility of TIBSOVO® in AML and MDS Also Accepted for Presentation –– Agios to Host Investor Webcast […]